Northern Trust’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
310,993
-6,768
-2% -$40.9K ﹤0.01% 3295
2026
Q1
$1.96M Buy
317,761
+30,433
+11% +$253K ﹤0.01% 2987
2025
Q4
$2.99M Sell
287,328
-25,826
-8% -$259K ﹤0.01% 2760
2025
Q3
$2.82M Sell
313,154
-28,595
-8% -$251K ﹤0.01% 2845
2025
Q2
$4.44M Sell
341,749
-96,676
-22% -$1.45M ﹤0.01% 2524
2025
Q1
$11.1M Buy
438,425
+35,021
+9% +$1.04M ﹤0.01% 1977
2024
Q4
$13.9M Buy
403,404
+26,106
+7% +$1.18M ﹤0.01% 1935
2024
Q3
$18.6M Buy
377,298
+64,800
+21% +$3.32M ﹤0.01% 1659
2024
Q2
$18.8M Sell
312,498
-11,287
-3% -$645K ﹤0.01% 1591
2024
Q1
$16.7M Sell
323,785
-5,735
-2% -$282K ﹤0.01% 1710
2023
Q4
$13.3M Buy
329,520
+90,326
+38% +$2.65M ﹤0.01% 1883
2023
Q3
$6.67M Buy
239,194
+16,610
+7% +$495K ﹤0.01% 2262
2023
Q2
$6.41M Buy
222,584
+38,007
+21% +$845K ﹤0.01% 2374
2023
Q1
$3.08M Buy
184,577
+28,822
+19% +$407K ﹤0.01% 2737
2022
Q4
$1.97M Buy
155,755
+5,344
+4% +$65K ﹤0.01% 3001
2022
Q3
$1.8M Buy
150,411
+1,286
+0.9% +$17.7K ﹤0.01% 3065
2022
Q2
$2.1M Buy
149,125
+15,366
+11% +$203K ﹤0.01% 3037
2022
Q1
$1.66M Buy
133,759
+58,815
+78% +$706K ﹤0.01% 3186
2021
Q4
$843K Buy
74,944
+4,179
+6% +$50.2K ﹤0.01% 3603
2021
Q3
$897K Buy
+70,765
New +$974K ﹤0.01% 3588

Other funds holding RXST

Northern Trust's RXST Position: Q2 2026 in Review

Northern Trust reduced its RxSight (RXST) stake by 2.1% in Q2 2026, selling an estimated $40.9K and leaving 310,993 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #3295.

Northern Trust first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $18.8M in Q2 2024. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Northern Trust held 310,993 shares of RxSight worth $1.5M as of Q2 2026.
  • Northern Trust sold 6,768 RxSight shares in Q2 2026, an estimated $40.9K.
  • RxSight made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3295 holding.
  • Northern Trust first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • Northern Trust's RxSight position peaked at $18.8M in Q2 2024.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.